Jane C. Sterling

Jane C. Sterling

Auto-generated profile, based on publicly available information

Jane C. Sterling

Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust , Cambridge

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in European Journal of Cancer
Verified
Journal Article
Closed access
LMLiam Masterson
Liam Masterson
MLMatt Lechner
Matt Lechner
SLSarah Loewenbein
Sarah Loewenbein
HMHassan Mohammed
Hassan Mohammed
CDCameron Davies-Husband
Cameron Davies-Husband
JSJane Sterling
Jane Sterling

1 June 2019 in British Journal of Dermatology
Verified
Journal Article
Closed access
SHS.S. Haque Hussain
S.S. Haque Hussain
JSJ.C. Sterling
J.C. Sterling

5 March 2026 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
GMGeorge W M Millington
George W M Millington
PPPriya U Patel
Priya U Patel
SCSer-Ling Chua
Ser-Ling Chua
ABAnthony Bewley
Anthony Bewley
JSJane C Sterling
Jane C Sterling
ZKZahra Mansour Kiaee
Zahra Mansour Kiaee
Lay Summary: Nodular prurigo (NP) is a chronic skin condition. Lesions can be either single or widespread on the body. Thus, it can have a negative impact on a person’s quality of life. The exact cause of NP is unknown, as several mechanisms play a role. These mechanisms sometimes overlap between physical and brain–behavioural elements. Dermatologists diagnose NP based on a history of long-lasting itching and scratching. A Guideline Development Group met to produce a new guideline for treating people with NP. The group included consultant dermatologists, a psychotherapist, dermatology trainees, a general practitioner and people with lived experience of NP. The group identified and reviewed the current literature on treating NP. They discussed the findings at length before producing a set of recommendations. The guideline will provide up-to-date management guidance for healthcare practitioners. Initial steps included taking a full history and examination of patients. This included causes of itch, patient education and reversing the itch–scratch habit. The first treatment option is usually topical therapy (applied to the skin). If this fails, other options include phototherapy and oral medications. Further treatments include nonsedating antihistamines and low-dose antidepressants. Steroid injections or cryotherapy (freezing with liquid nitrogen) are options for single lesions. The guideline provides recommendations for treating people with NP. It also includes recommendations for future research and audit points for hospitals. A patient information leaflet is available on the British Association of Dermatologists’ website (https://www.skinhealthinfo.org.uk/condition/nodular-prurigo).

20 November 2019
Verified
Book Chapter
Closed access
PDF file
SLSusan Lewis‐Jones
Susan Lewis‐Jones
JSJane C. Sterling
Jane C. Sterling